Pathfinder
Editor, Senior Moderator
OPINION LETTERS
China Suppresses Covid Research in the West
Part of the Western medical-journal establishment is complicit. We know from experience.
March 29, 2022 1:14 pm ET
....
Early in 2020, we wrote a paper estimating Covid cases and deaths in Wuhan, China, based on confirmed cremation operations there. We also used Covid doubling rates published by Hong Kong researchers in the Lancet, as well as China’s figures for deaths in pre-Covid Wuhan. The paper concluded that official Chinese figures at the end of January 2020 were underestimating Covid cases and deaths by factors of 5 to 10, depending on the dates examined.
We sent the paper for posting on the major medical preprint website medRxiv in early February 2020. On Feb. 13 the “medRxiv Team” informed us that it would not post the paper because it was “inappropriate.” The acknowledged purpose of these preprint sites is to post possibly useful findings sooner than the lengthy peer-review process allows. We had never heard of a preprint site refusing a paper from suitably credentialed people. But we have since learned that other researchers have encountered similar rejections when their findings conflicted with the official narrative coming out of China.
...
Assoc. Prof. Mai He
Washington University Medical School
St. Louis, Mo.
Em. Prof. Lucia Dunn
Ohio State University
Columbus, Ohio
https://www.wsj.com/articles/china-...dical-journal-pandemic-censorship-11648499707
China Suppresses Covid Research in the West
Part of the Western medical-journal establishment is complicit. We know from experience.
March 29, 2022 1:14 pm ET
....
Early in 2020, we wrote a paper estimating Covid cases and deaths in Wuhan, China, based on confirmed cremation operations there. We also used Covid doubling rates published by Hong Kong researchers in the Lancet, as well as China’s figures for deaths in pre-Covid Wuhan. The paper concluded that official Chinese figures at the end of January 2020 were underestimating Covid cases and deaths by factors of 5 to 10, depending on the dates examined.
We sent the paper for posting on the major medical preprint website medRxiv in early February 2020. On Feb. 13 the “medRxiv Team” informed us that it would not post the paper because it was “inappropriate.” The acknowledged purpose of these preprint sites is to post possibly useful findings sooner than the lengthy peer-review process allows. We had never heard of a preprint site refusing a paper from suitably credentialed people. But we have since learned that other researchers have encountered similar rejections when their findings conflicted with the official narrative coming out of China.
...
Assoc. Prof. Mai He
Washington University Medical School
St. Louis, Mo.
Em. Prof. Lucia Dunn
Ohio State University
Columbus, Ohio
https://www.wsj.com/articles/china-...dical-journal-pandemic-censorship-11648499707

